CD177 Enhances the Detection of Myelodysplastic Syndrome by Flow Cytometry

The nonconservative CD177 single-nucleotide polymorphism c.1291G>A is a genetic determinant for human neutrophil antigen-2 atypical/low expression and deficiency

(2019) Jianming Wu et al.   TRANSFUSION

Revising flow cytometric mini-panel for diagnosing low-grade myelodysplastic syndromes: Introducing a parameter quantifying CD33 expression on CD34+ cells

(2018) Kiyoyuki Ogata et al.   LEUKEMIA RESEARCH

Gene silencing and a novel monoallelic expression pattern in distinct CD177 neutrophil subsets

(2017) Claudia Eulenberg-Gustavus et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Cutting Edge: Flow Cytometry in Myelodysplastic Syndromes

(2017) Arjan A. van de Loosdrecht et al.   Journal of the National Comprehensive Cancer Network

The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia

(2016) D. A. Arber et al.   BLOOD

Identification of a gene expression signature in peripheral blood of multiple sclerosis patients treated with disease-modifying therapies

(2016) Chiara Cordiglieri et al.   CLINICAL IMMUNOLOGY

Multiparameter flow cytometry is instrumental to distinguish myelodysplastic syndromes from non-neoplastic cytopenias

(2016) Eline M.P. Cremers et al.   EUROPEAN JOURNAL OF CANCER

Implementation of erythroid lineage analysis by flow cytometry in diagnostic models for myelodysplastic syndromes

(2016) Eline M.P. Cremers et al.   HAEMATOLOGICA

Immunophenotypic analysis of erythroid dysplasia in myelodysplastic syndromes. A report from the IMDSFlow working group

(2016) Theresia M. Westers et al.   HAEMATOLOGICA

Identification of CD177 as the most dysregulated parameter in a microarray study of purified neutrophils from septic shock patients

(2016) Julie Demaret et al.   IMMUNOLOGY LETTERS

Heterogeneity of Human Neutrophil CD177 Expression Results from CD177P1 Pseudogene Conversion

(2016) Zuopeng Wu et al.   PLoS Genetics

Implementation of erythroid lineage analysis by flow cytometry in diagnostic models for myelodysplastic syndromes

(2016) Eline M.P. Cremers et al.   HAEMATOLOGICA

Immunophenotypic analysis of erythroid dysplasia in myelodysplastic syndromes. A report from the IMDSFlow working group

(2016) Theresia M. Westers et al.   HAEMATOLOGICA

The molecular pathogenesis of the myelodysplastic syndromes

(2015) Andrea Pellagatti et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

Multicentric study underlining the interest of adding CD5, CD7 and CD56 expression assessment to the flow cytometric Ogata score in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms

(2015) V. Bardet et al.   HAEMATOLOGICA

The myelodysplastic syndromes flow cytometric score: a three-parameter prognostic flow cytometric scoring system

(2015) C Alhan et al.   LEUKEMIA

Genetic Mechanism of Human Neutrophil Antigen 2 Deficiency and Expression Variations

(2015) Yunfang Li et al.   PLoS Genetics

Multicentric study underlining the interest of adding CD5, CD7 and CD56 expression assessment to the flow cytometric Ogata score in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms

(2015) V. Bardet et al.   HAEMATOLOGICA

Age-related mutations associated with clonal hematopoietic expansion and malignancies

(2014) Mingchao Xie et al.   NATURE MEDICINE

Clonal Hematopoiesis and Blood-Cancer Risk Inferred from Blood DNA Sequence

(2014) Giulio Genovese et al.   NEW ENGLAND JOURNAL OF MEDICINE

Establishment and Validation of an Updated Diagnostic FCM Scoring System Based on Pooled Immunophenotyping in CD34+ Blasts and Its Clinical Significance for Myelodysplastic Syndromes

(2014) Feng Xu et al.   PLoS One

CD177 Expression on Neutrophils

(2013) Howard J. Meyerson et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

Clinical and biological implications of driver mutations in myelodysplastic syndromes

(2013) E. Papaemmanuil et al.   BLOOD

Combined flow cytometric assessment of CD45, HLA-DR, CD34, and CD117 expression is a useful approach for reliable quantification of blast cells in myelodysplastic syndromes

(2013) Alex F. Sandes et al.   CYTOMETRY PART B-CLINICAL CYTOMETRY

Diagnostic application and clinical significance of FCM progress scoring system based on immunophenotyping in CD34+ blasts in myelodysplastic syndromes

(2013) Feng Xu et al.   CYTOMETRY PART B-CLINICAL CYTOMETRY

Flow cytometric detection of dyserythropoiesis: a sensitive and powerful diagnostic tool for myelodysplastic syndromes

(2013) S Mathis et al.   LEUKEMIA

Landscape of genetic lesions in 944 patients with myelodysplastic syndromes

(2013) T Haferlach et al.   LEUKEMIA

Comparative evaluation of the role of the adhesion molecule CD177 in neutrophil interactions with platelets and endothelium

(2012) Boris K. Pliyev et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

Serial assessment of suspected myelodysplastic syndromes: significance of flow cytometric findings validated by cytomorphology, cytogenetics, and molecular genetics

(2012) W. Kern et al.   HAEMATOLOGICA

Multicenter validation of a reproducible flow cytometric score for the diagnosis of low-grade myelodysplastic syndromes: results of a European LeukemiaNET study

(2012) M. G. Della Porta et al.   HAEMATOLOGICA

New Comprehensive Cytogenetic Scoring System for Primary Myelodysplastic Syndromes (MDS) and Oligoblastic Acute Myeloid Leukemia After MDS Derived From an International Database Merge

(2012) Julie Schanz et al.   JOURNAL OF CLINICAL ONCOLOGY

Standardization of flow cytometry in myelodysplastic syndromes: a report from an international consortium and the European LeukemiaNet Working Group

(2012) T M Westers et al.   LEUKEMIA

Rationale for the clinical application of flow cytometry in patients with myelodysplastic syndromes: position paper of an International Consortium and the European LeukemiaNet Working Group

(2012) Arjan A. van de Loosdrecht et al.   LEUKEMIA & LYMPHOMA

Flow cytometric scoring system as a diagnostic and prognostic tool in myelodysplastic syndromes

(2011) Sung-Chao Chu et al.   LEUKEMIA RESEARCH

Myelodysplastic syndromes

(2011) Jiehao Zhou et al.   SEMINARS IN DIAGNOSTIC PATHOLOGY

Flow cytometric scoring system (FCMSS) assisted diagnosis of myelodysplastic syndromes (MDS) and the biological significance of FCMSS-based immunophenotypes

(2010) Feng Xu et al.   BRITISH JOURNAL OF HAEMATOLOGY

Clinical utility of multiparameter flow cytometry in the diagnosis of 1013 patients with suspected myelodysplastic syndrome

(2010) Wolfgang Kern et al.   CANCER

Validation of a flow cytometric scoring system as a prognostic indicator for posttransplantation outcome in patients with myelodysplastic syndrome

(2008) B. L. Scott et al.   BLOOD

Aberrant DNA methylation is a dominant mechanism in MDS progression to AML

(2008) Y. Jiang et al.   BLOOD

Flow cytometric parameters with little interexaminer variability for diagnosing low-grade myelodysplastic syndromes

(2008) Chikako Satoh et al.   LEUKEMIA RESEARCH

Flow cytometry in myelodysplastic syndromes: Report from a working conference

(2007) Michael R. Loken et al.   LEUKEMIA RESEARCH